Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 20/02/20 → 1/04/22 |
Keywords
- Clinical trial
- phase 3 study
- lupus
- SLE
- systemic lupus erythematosus (SLE)
- treatment safety
Clinical Trial Phase
- Phase III (a & b)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients with Systemic Lupus Erythematosus (SLE)
- Hoi, Alberta (Primary Chief Investigator (PCI))
Project: Research